Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial

Prostate cancer screening remains controversial because potential mortality or quality-of-life benefits may be outweighed by harms from overdetection and overtreatment. To evaluate the effect of a single prostate-specific antigen (PSA) screening intervention and standardized diagnostic pathway on pr...

Full description

Bibliographic Details

Published in:	JAMA : the journal of the American Medical Association Vol. 319; no. 9; p. 883
Main Authors:	Martin, Richard M, Donovan, Jenny L, Turner, Emma L, Metcalfe, Chris, Young, Grace J, Walsh, Eleanor I, Lane, J Athene, Noble, Sian, Oliver, Steven E, Evans, Simon, Sterne, Jonathan A C, Holding, Peter, Ben-Shlomo, Yoav, Brindle, Peter, Williams, Naomi J, Hill, Elizabeth M, Ng, Siaw Yein, Toole, Jessica, Tazewell, Marta K, Hughes, Laura J, Davies, Charlotte F, Thorn, Joanna C, Down, Elizabeth, Davey Smith, George, Neal, David E, Hamdy, Freddie C
Format:	Journal Article
Language:	English
Published:	United States 06.03.2018
Subjects:	Age Distribution Aged Early Detection of Cancer Follow-Up Studies Humans Male Mass Screening Middle Aged Primary Health Care Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - diagnosis Prostatic Neoplasms - mortality Social Class United Kingdom - epidemiology
ISSN:	1538-3598, 1538-3598
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!